.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Daiichi Sankyo
McKinsey
Citi
Express Scripts
US Army
Mallinckrodt
US Department of Justice
Fish and Richardson

Generated: July 21, 2017

DrugPatentWatch Database Preview

Chlorpheniramine maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for chlorpheniramine maleate and what is the scope of chlorpheniramine maleate freedom to operate?

Chlorpheniramine maleate
is the generic ingredient in twenty-four branded drugs marketed by Sun Pharm Inds, Pharmavite, Purepac Pharm, Impax Labs, Newtron Pharms, Pharm Assoc, Bel Mar, Schering, Schering Plough, Roxane, Avanthi Inc, Halsey, Vitarine, Bayer Healthcare Llc, Elkins Sinn, Watson Labs, Lederle, Panray, Alza, Lannett, Pharmeral, Pioneer Pharms, Aurolife Pharma Llc, Bell Pharma, Kv Pharm, Glaxosmithkline, Anabolic, Ivax Sub Teva Pharms, Bayer Pharms, Pvt Form, West Ward, Spriaso Llc, Cypress Pharm, Tris Pharma Inc, Acella Pharms Llc, Paddock Llc, Mayne Pharma Inc, Bio-pharm Inc, Pfizer, Novartis, Graham Dm, Cent Pharms, Schwarz Pharma, and Fisons, and is included in sixty-two NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate. Five suppliers are listed for this compound.

Summary for Generic Name: chlorpheniramine maleate

Tradenames:24
Patents:6
Applicants:44
NDAs:62
Drug Master File Entries: see list29
Suppliers / Packagers: see list5
Bulk Api Vendors: see list54
Clinical Trials: see list193
Patent Applications: see list6,964
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:chlorpheniramine maleate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pvt Form
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET;ORAL080786-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmavite
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET;ORAL085104-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Elkins Sinn
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET;ORAL080938-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Schwarz Pharma
CODIMAL-L.A. 12
chlorpheniramine maleate; pseudoephedrine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018935-001Apr 15, 1985DISCNNoNo► Subscribe► Subscribe
West Ward
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET;ORAL083787-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: chlorpheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 19944,576,604► Subscribe
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 19944,857,330► Subscribe
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 19944,673,405► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
US Army
Johnson and Johnson
Harvard Business School
Queensland Health
Deloitte
Novartis
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot